Literature DB >> 18285444

The PKCdelta -Abl complex communicates ER stress to the mitochondria - an essential step in subsequent apoptosis.

Xin Qi1, Daria Mochly-Rosen.   

Abstract

Conditions that compromise protein folding in the endoplasmic reticulum trigger the unfolded protein response (UPR), which either restores proper protein folding or results in cellular demise through apoptosis. In this study, we found that, in response to ER stress in vivo and in vitro, PKCdelta translocates to the ER where it binds to the tyrosine kinase Abl. Tyrosine phosphorylation and kinase activity of PKCdelta are required for PKCdelta binding to Abl in the ER. Moreover, we found that inhibition of PKCdelta by the PKCdelta-specific peptide inhibitor deltaV1-1 or by silencing of PKCdelta reduces ER-stress-induced JNK activation and inhibits ER-stress-mediated apoptosis. Furthermore, the inhibitor of PKCdelta kinase activity rottlerin blocks the translocation of the PKCdelta-Abl complex from the ER to the mitochondria and confers protection against apoptosis. Thus, PKCdelta communicates ER stress to the mitochondria by binding to ER-localized Abl. The PKCdelta-Abl complex then translocates to the mitochondria, communicating ER stress to this organelle, thereby, triggering apoptosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18285444     DOI: 10.1242/jcs.024653

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  47 in total

1.  The many hats of protein kinase Cδ: one enzyme with many functions.

Authors:  Nir Qvit; Daria Mochly-Rosen
Journal:  Biochem Soc Trans       Date:  2014-12       Impact factor: 5.407

2.  Association with endoplasmic reticulum promotes proteasomal degradation of GADD34 protein.

Authors:  Wei Zhou; Matthew H Brush; Meng S Choy; Shirish Shenolikar
Journal:  J Biol Chem       Date:  2011-04-25       Impact factor: 5.157

Review 3.  Endoplasmic reticulum stress and type 2 diabetes.

Authors:  Sung Hoon Back; Randal J Kaufman
Journal:  Annu Rev Biochem       Date:  2012-03-23       Impact factor: 23.643

4.  Drp1 stabilizes p53 on the mitochondria to trigger necrosis under oxidative stress conditions in vitro and in vivo.

Authors:  Xing Guo; Hiromi Sesaki; Xin Qi
Journal:  Biochem J       Date:  2014-07-01       Impact factor: 3.857

5.  PKCδ regulates hepatic insulin sensitivity and hepatosteatosis in mice and humans.

Authors:  Olivier Bezy; Thien T Tran; Jussi Pihlajamäki; Ryo Suzuki; Brice Emanuelli; Jonathan Winnay; Marcelo A Mori; Joel Haas; Sudha B Biddinger; Michael Leitges; Allison B Goldfine; Mary Elizabeth Patti; George L King; C Ronald Kahn
Journal:  J Clin Invest       Date:  2011-05-16       Impact factor: 14.808

Review 6.  Oxidative stress-induced signaling pathways implicated in the pathogenesis of Parkinson's disease.

Authors:  Georgia S Gaki; Athanasios G Papavassiliou
Journal:  Neuromolecular Med       Date:  2014-02-13       Impact factor: 3.843

7.  Inhibition of mitochondrial fragmentation diminishes Huntington's disease-associated neurodegeneration.

Authors:  Xing Guo; Marie-Helene Disatnik; Marie Monbureau; Mehrdad Shamloo; Daria Mochly-Rosen; Xin Qi
Journal:  J Clin Invest       Date:  2013-11-15       Impact factor: 14.808

Review 8.  Current and emerging therapeutic targets for Parkinson's disease.

Authors:  Tanvi Pingale; Girdhari Lal Gupta
Journal:  Metab Brain Dis       Date:  2020-10-22       Impact factor: 3.584

9.  PKCdelta blues for the beta-cell.

Authors:  Carsten Schmitz-Peiffer; Trevor J Biden
Journal:  Diabetes       Date:  2010-01       Impact factor: 9.461

10.  Overexpression of kinase-negative protein kinase Cdelta in pancreatic beta-cells protects mice from diet-induced glucose intolerance and beta-cell dysfunction.

Authors:  Anita M Hennige; Felicia Ranta; Isabel Heinzelmann; Martina Düfer; Diana Michael; Heidi Braumüller; Stefan Z Lutz; Reiner Lammers; Gisela Drews; Fatima Bosch; Hans-Ulrich Häring; Susanne Ullrich
Journal:  Diabetes       Date:  2009-10-13       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.